A pharmaceutical composition comprising a substance inhibiting HSP47 production, selected from the group consisting of a malt extract, a flavonoid compound, a protein-bound-polysaccharide obtained from a fungus belonging to Coriolus versicolor, a paeoniflorin derivative, a tocopherol derivative, and a ferulic acid derivative, and a pharmaceutically acceptable carrier is disclosed. The substance inhibiting HSP47 production can efficiently improve physiological conditions of a patient suffering from diseases exhibiting pathosis of overproduction of the extracellular matrix, and efficiently treat such diseases. Further, the substance is useful for preventing or treating various diseases accompanied with abnormal growth of the vascularization.
本发明公开了一种药物组合物,该组合物包含一种抑制 HSP47 生成的物质,该物质选自麦芽
提取物、
黄酮类化合物、从属于 Coriolus versicolor 的真菌中获得的蛋白结合
多糖、
芍药苷衍
生物、
生育酚衍
生物和
阿魏酸衍
生物组成的组,以及一种药学上可接受的载体。这种抑制 HSP47 生成的物质可以有效改善患有细胞外基质过度生成病症的患者的生理状况,并有效治疗此类疾病。此外,该物质还可用于预防或治疗伴有血管异常生长的各种疾病。